Home > Insider Trading > Filing (0000899243-23-010819)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1745999	Beam Therapeutics Inc.	BEAM	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1786304	M. John Evans	C/O Beam Therapeutics Inc., 238 Main Street Cambridge MA 02142	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-04-03	5,161	$30.31	1,124,472	No	4	S	Direct
Common Stock	Disposition	2023-04-04	6,493	$29.09	1,117,979	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	103,000	Indirect	By John M. Evans, III 2018 Irrevocable Trust

Footnotes

These shares of common stock were sold pursuant to a a Rule 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023.
Includes 480 shares acquired by the Reporting Person under the Beam Therapeutics Inc. Amended and Restated 2019 Employee Stock Purchase Plan on March 31, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.81 to $29.10, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.